Principal Financial Group
LYEL icon

Principal Financial Group’s Lyell Immunopharma LYEL Stock Holding History

Principal Financial Group’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-550
Closed -$5.92K – 2281
2025
Q1 		$5.92K Hold
550
– – ﹤0.01% 2166
2024
Q4 		$7.04K Sell
550
-11
-2% -$218 ﹤0.01% 2206
2024
Q3 		$15.5K Sell
561
-765
-58% -$22.5K ﹤0.01% 2214
2024
Q2 		$38.4K Sell
1,326
-1,587
-54% -$75.6K ﹤0.01% 2304
2024
Q1 		$130K Sell
2,913
-233
-7% -$9.98K ﹤0.01% 2245
2023
Q4 		$122K Sell
3,146
-258
-8% -$9.29K ﹤0.01% 2239
2023
Q3 		$100K Buy
3,404
+396
+13% +$18.8K ﹤0.01% 2282
2023
Q2 		$191K Buy
3,008
+277
+10% +$15.3K ﹤0.01% 2192
2023
Q1 		$129K Buy
2,731
+288
+12% +$15.4K ﹤0.01% 2258
2022
Q4 		$170K Buy
2,443
+158
+7% +$15.7K ﹤0.01% 2224
2022
Q3 		$335K Buy
2,285
+483
+27% +$65.4K ﹤0.01% 2052
2022
Q2 		$235K Sell
1,802
-584
-24% -$59.7K ﹤0.01% 2252
2022
Q1 		$241K Buy
2,386
+953
+67% +$115K ﹤0.01% 2294
2021
Q4 		$222K Buy
+1,433
New +$320K ﹤0.01% 2331

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group's LYEL Position: Q2 2025 in Review

Principal Financial Group sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 550 shares — an estimated $5.92K sold.

Principal Financial Group first reported a position in LYEL in Q4 2021 and held it in 14 quarters. The position peaked at $335K in Q3 2022. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • Principal Financial Group reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • Principal Financial Group sold 550 Lyell Immunopharma shares in Q2 2025, an estimated $5.92K.
  • Principal Financial Group first reported a position in Lyell Immunopharma in Q4 2021 and held it in 14 quarters.
  • Principal Financial Group's Lyell Immunopharma position peaked at $335K in Q3 2022.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on Principal Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.